Showing results (11-20 of 88) with videos related to
Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Ovarian cancer: genomic analysisW Wei, D Dizon, V Vathipadiekal, et al.Oncogene|March 1, 1994
Mechanism of action of a dominant-negative mutant of c-JunP H Brown, T K Chen, M J BirrerOncogene|June 23, 2001
In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancersM Ebina, A Martínez, M J Birrer, et al.Oncogene|December 1, 1994
Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutantU R Rapp, J Troppmair, T Beck, et al.Cancer Research|June 1, 1997
FHIT gene expression in human ovarian, endometrial, and cervical cancer cell linesD T Hendricks, R Taylor, M Reed, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancerJ Krzystyniak, L Ceppi, D S Dizon, et al.Cancer Research|June 5, 2001
The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastineM Fan, M E Goodwin, M J Birrer, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|October 1, 1991
The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiationE Szabo, L H Preis, P H Brown, et al.Molecular and Cellular Biology|June 25, 1998
AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cellsS M Jacobs-Helber, A Wickrema, M J Birrer, et al.Cancer Research|July 15, 1997
Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cellsL M Smith, M J Birrer, M R Stampfer, et al.Pageof 9